Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development
about
Updates on the web-based VIOLIN vaccine database and analysis systemProtegen: a web-based protective antigen database and analysis systemStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensOntology-supported research on vaccine efficacy, safety and integrative biological networksA continuous peptide epitope reacting with pandemic influenza AH1N1 predicted by bioinformatic approaches.DNAVaxDB: the first web-based DNA vaccine database and its data analysis.Vaxvec: The first web-based recombinant vaccine vector database and its data analysisValue of a newly sequenced bacterial genomeOntology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network.Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLINGenome-wide prediction of vaccine targets for human herpes simplex viruses using Vaxign reverse vaccinologyImmunogenic and invasive properties of Brucella melitensis 16M outer membrane protein vaccine candidates identified via a reverse vaccinology approachPreventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Jenner-predict server: prediction of protein vaccine candidates (PVCs) in bacteria based on host-pathogen interactions.Identification of novel adhesins of M. tuberculosis H37Rv using integrated approach of multiple computational algorithms and experimental analysis.A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithmsEmerging vaccine informatics.Genome informatics and vaccine targets in Corynebacterium urealyticum using two whole genomes, comparative genomics, and reverse vaccinology.VacSol: a high throughput in silico pipeline to predict potential therapeutic targets in prokaryotic pathogens using subtractive reverse vaccinology.Immunoprotective Efficacy of Acinetobacter baumannii Outer Membrane Protein, FilF, Predicted In silico as a Potential Vaccine CandidateHIV-2 and its role in conglutinated approach towards Acquired Immunodeficiency Syndrome (AIDS) Vaccine DevelopmentGenome Sequence of an Environmental Isolate of the Bacterial Pathogen Legionella pneumophila.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Urinary tract infections: current and emerging management strategies.Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design.Genome Report: Identification and Validation of Antigenic Proteins from Pajaroellobacter abortibovis Using De Novo Genome Sequence Assembly and Reverse Vaccinology.An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach.Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.Ontology-based literature mining of E. coli vaccine-associated gene interaction networks.Cyclic di-nucleotides: new era for small molecules as adjuvants.Synthetic biology and personalized medicine.Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.The Use of Reverse Vaccinology in the Design and Construction of Nano-glycoconjugate Vaccines against Burkholderia pseudomallei.Harnessing the power of genomics and immunoinformatics to produce improved vaccines.Identification of Novel Vaccine Candidates against Campylobacter through Reverse Vaccinology.Systematic annotation and analysis of "virmugens"-virulence factors whose mutants can be used as live attenuated vaccines.In silico identification and characterization of a hypothetical protein of Mycobacterium tuberculosis EAI5 as a potential virulent factor.Towards developing a vaccine for rheumatic heart disease.Vacceed: a high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology.
P2860
Q24567754-7B1FE202-0230-46DB-8173-CC4C0CEC76E3Q24607933-C5A251A4-8323-4557-9BA3-64E85F5F4B40Q26777382-293F321E-1A47-4DB1-B440-01BEE746C889Q27005991-BC54CB38-FBF5-4C9C-9537-FB3965A8F524Q30372843-81504F85-25A9-468E-8DB9-F166E4398B3CQ30841376-80947FD4-32C2-48D8-9564-A836C61C631EQ30996881-8AEFE2E5-BB4D-4E3A-84B7-0C0AAE6D4F27Q33728835-89384672-4EB9-46F9-9A44-12C19930C187Q34003852-C9527683-AFB7-433C-AD21-7016E17DE51BQ34160248-A7D2E0F1-2A0B-4A26-888F-DEF59AD37A4FQ34628398-873FDFFA-A64B-446C-953A-E03128E9BE7CQ34637943-C9594FA1-7DA6-4F90-A39F-46C9F23AB81EQ34641267-EAB3FD4E-863D-4342-A2C6-31242E806108Q34787708-7625283B-4610-48E2-9FAD-2751948F0B9EQ34903880-04DBE98E-5718-42C1-9892-A0E464490EDAQ35030321-48B6DE8C-A37A-4BF0-B3CC-67F007361D3AQ35100809-FB4DA1E1-E02E-465A-9F38-475CA21723CCQ35652071-273BE58B-34F5-4CA4-B815-212D4ECF91FEQ36278990-DC1635D6-3C4B-4662-8181-C5D00EDE17D6Q36573679-4EC1D33F-5F81-4A32-BE5F-9B55AC90141BQ36651031-E2610ECB-98E9-4951-A41E-2C369B75ED62Q36909874-3BD180D8-7E81-4D7C-99BE-A4D7ACB8DFE1Q36951570-5FDF5A5F-08E3-4291-9B75-AC9CD0216743Q37084979-3ECB31B9-6A82-478A-AF1D-156AECD6A352Q37581984-66E4FDC6-AC3A-498B-B965-425A6466126DQ37629284-E51BE320-5CE9-4EC1-A8B9-EB9A1D326B43Q37690954-F246D8FE-6183-4AD4-B529-8D5827837308Q37691079-3E1DAD85-EB62-443B-989A-EB133E7CD36CQ37697940-E4382EC5-68EC-4815-BA17-3469F659AFE9Q37940637-261891E3-A458-4AEF-948D-2894E49058FAQ38036084-ED66F525-BC36-478E-A40C-C11AF75B9B0AQ38037536-61B7B0F2-333A-48B9-AD22-E65D2C7907BCQ38110546-85C2C474-982A-4004-BE6E-AC4016BA79BAQ40048191-6C7B8502-9312-4172-BA39-7BDCFD4A28B0Q40162376-9D067FFB-04E5-4012-A403-AA0059A8161FQ40613856-8076A982-5D61-4725-A686-D50E9A8EFCEFQ41830548-F28C6449-6D31-432D-A2A4-6E84A9DCDF27Q41852831-42EBCA1C-2E0D-4E37-9803-63A2D22A784AQ41928281-0DBB786B-5411-4A43-AC7B-31963ADF9962Q42024639-6284F790-71E4-4AD7-8FF4-95440ECC57BE
P2860
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vaxign: the first web-based va ...... ations for vaccine development
@ast
Vaxign: the first web-based va ...... ations for vaccine development
@en
Vaxign: the first web-based va ...... ations for vaccine development
@en-gb
Vaxign: the first web-based va ...... ations for vaccine development
@nl
type
label
Vaxign: the first web-based va ...... ations for vaccine development
@ast
Vaxign: the first web-based va ...... ations for vaccine development
@en
Vaxign: the first web-based va ...... ations for vaccine development
@en-gb
Vaxign: the first web-based va ...... ations for vaccine development
@nl
altLabel
Vaxign: The First Web-Based Va ...... ations for Vaccine Development
@en
prefLabel
Vaxign: the first web-based va ...... ations for vaccine development
@ast
Vaxign: the first web-based va ...... ations for vaccine development
@en
Vaxign: the first web-based va ...... ations for vaccine development
@en-gb
Vaxign: the first web-based va ...... ations for vaccine development
@nl
P2860
P3181
P356
P1476
Vaxign: the first web-based va ...... ations for vaccine development
@en
P2093
Zuoshuang Xiang
P2860
P304
P3181
P356
10.1155/2010/297505
P407
P577
2010-01-01T00:00:00Z